The chromatin conformation landscape of Alzheimer’s disease

R Nativio,Y Lan,G Donahue,O Shcherbakova,N Barnett,KR Titus,H Chandrashekar,JE Phillips-Cremins,NM Bonini,SL Berger
DOI: https://doi.org/10.1101/2024.04.09.588722
2024-04-13
Abstract:We have been investigating epigenetic alterations in the brain during human aging and Alzheimer’s disease (AD), and have evidence for histone acetylation both protecting the aging epigenome and driving AD. Here we extend our studies to chromatin architecture via looping studies, and with binding studies of key proteins required for looping: CTCF and RAD21. We detected changes in CTCF and RAD21 levels and localization, finding major changes in CTCF in AD compared to fewer changes in healthy aging. In our study of 3D genome conformation changes, we identified stable topological associating domains (TADs) in Old and AD; in contrast, in AD, there is loss of interaction at genomic sites/loops within TADs, likely reflecting the loss of CTCF. We identified genes and potential transcription factor binding at the loops that are lost in AD. in addition, we found enrichment of CTCF peak losses for AD eQTLs, suggesting that architectural dysfunction has a role in Alzheimer’s. Functional experiments lowering the homologues of several key genes in a model of Aβ42 toxicity exacerbate neurodegeneration. Taken together, these data indicate both functional protections and losses occur in the Alzheimer’s brain genome compared to normal aging.
Neuroscience
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the changes in chromatin conformation in Alzheimer's disease (AD) and their impact on gene expression. Specifically, researchers investigated how these changes affect gene expression patterns in AD by analyzing the changes of two proteins, CTCF and RAD21, which play key roles in maintaining chromatin structure. In addition, the study also explored the differences between these changes and the healthy aging process, and whether these changes are related to the genetic risk factors of AD. ### Main research questions include: 1. **Changes of CTCF and RAD21 in AD**: - Researchers detected the changes in the binding sites of CTCF and RAD21 in samples from AD patients, healthy elderly people, and young people by using ChIP - seq technology. - The results showed that in AD, the binding sites of CTCF were significantly reduced, while the binding sites of RAD21 were increased, but the number was relatively small. 2. **Changes in 3D genome conformation**: - Through HiC and CTCF HiChIP technologies, researchers further analyzed the changes in 3D genome structure. - It was found that although TADs remained stable in AD, long - range chromatin interactions were significantly reduced in the regions where CTCF binding sites were reduced. 3. **Impact on gene expression**: - Researchers explored the impact of changes in CTCF and RAD21 binding sites on gene expression through RNA - seq data. - The results indicated that the reduction of CTCF was related to the down - regulation of certain gene expressions, especially in enhancer - promoter interactions. 4. **Functional verification**: - To verify the functional significance of these changes, researchers conducted experiments in Drosophila models and found that reducing the expression of homologous genes of CTCF or Pou6F1 would exacerbate the neurodegenerative lesions caused by Aβ42. 5. **Association with genetic risk factors**: - Researchers also explored whether AD - related single - nucleotide polymorphisms (SNPs) and expression quantitative trait loci (eQTLs) were enriched in the regions where CTCF binding sites were reduced. - The results showed that AD eQTLs were significantly enriched in the regions where CTCF binding sites were reduced, suggesting that these changes may be related to the genetic risk of AD. In conclusion, this paper aims to reveal the molecular mechanisms of chromatin conformation changes in AD and their impact on gene expression and disease progression through multi - angle experimental and technical means.